Early Career Researcher prize

Early Career Researcher prize

Since 2017 we have run an FTD UK Early Career Researcher prize, now sponsored by the Alzheimer’s Society. We have two categories – Clinical Science and Basic Science. From 2023 the Basic Science prize has been named in memory of Stuart Pickering-Brown, one of the founders of FTD UK.

Any junior researcher who is earlier in their career than 5 working years after completion of their PhD can enter the prize. Abstract submission is now open for the 2024 meeting:

  • Only one submission can be made for each person and must be in a standard format:
    • Title of abstract
    • Name of person submitting it (please do not add any other names)
    • Affiliations
    • Highest degree (and if PhD, the year awarded)
    • Abstract itself (max 250 words): Background, Methods, Results, Conclusion.
  • Abstracts should be sent via email to frontotemporaldementiauk@gmail.com by the end of March 2024.
  • Each abstract will be judged by four independent national and/or international reviewers.
  • Winners must be available to present their work via an oral presentation at the annual FTD UK meeting and will be announced by the end of April each year. There will be no posters at the meeting for other submissions.


Previous winners


Clinical Science: Rhian Convery. (UCL) – The Ignite app detects early cognitive impairment in genetic FTD within the GENFI cohort.

Basic Science: Puja Mehta (UCL) – Combined rescue of STMN2 and UNC13A mis-splicing in ALS-FTD with TDP-43 proteinopathy using a novel therapeutic approach.


Clinical Science: Maura Malpetti (University of Cambridge) – Peripheral and central markers of inflammation in frontotemporal dementia and related conditions

Basic Science: Javier Bautista (UCL) – Mitochondrial dysfunction is involved in progranulin-associated frontotemporal dementia


Clinical Science (shared): Martina Bocchetta (UCL) – Thalamic nuclei in frontotemporal dementia: mediodorsal nucleus involvement is universal but pulvinar atrophy is unique to C9orf72

Clinical Science (shared): Carolin Heller (UCL) – Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia

Basic Science: Martha Foiani (UCL) – Identification of antibodies that selectively bind specific tauopathies


Clinical Science: Richard Bevan-Jones (University of Cambridge) – The role of neuroinflammation in the pathophysiology of Frontotemporal dementia: a positron emission tomography study

Basic Science (shared): Carolin Koriath (UCL) – ApoE4 lowers age at onset in patients with frontotemporal dementia and tauopathy independent of amyloid-beta copathology

Basic Science (shared): Sarah Ryan (University of Manchester) – C9orf72 dipeptides differentially impair nucleocytoplasmic transport


Clinical Science: Katrina Moore (UCL) – Symptom onset in genetic frontotemporal dementia

Basic Science: Francesco Paonessa (University of Cambridge) – Altered microtubule dynamics lead to alteration of the nuclear lamina in FTD-MAPT neurons